SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the third quarter 2026 before U.S. markets open on Tuesday, ...

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that it will ...

Our genes evolved to fight ancient threats, but in the modern world, some of those changes may be turning against us.

The gains of scientific advancements in treatment are shadowed by the cuts coming in Medicaid coverage at rare disease fair.

A massive genetic analysis reveals that while men and women share much of the underlying risk for anxiety, they also possess ...

Downtown Cairo came alive Saturday night as Cairo Main Street and Turner’s Tribe hosted their annual Downtown Concert, ...

The immortal jellyfish is capable of winding back its lifecycle to become young again. Scientists are unlocking its cellular ...

Opus Genetics, Inc., a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), announced that the ...

DURHAM, NC (October 19, 2026) — Today, Congresswoman Valerie Foushee (NC-04) introduced a resolution designating the third ...

FDA expands the approved use of phentolamine ophthalmic solution 0.75% to include age-related near vision impairment, which affects millions of adults in the United States. Approv ...